NCT07539974

Brief Summary

This study investigates the effect of threshold inspiratory muscle training on diaphragm thickness and diaphragm excursion, measured using ultrasonography, in patients with stable chronic obstructive pulmonary disease (COPD).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Apr 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Apr 2026Sep 2026

Study Start

First participant enrolled

April 1, 2026

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 13, 2026

Last Update Submit

April 20, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Diaphragm Thickness (cm)

    Diaphragm thickness reflects the structural characteristics of the diaphragm muscle and is measured at end-inspiration and end-expiration using ultrasonography. The values are expressed in centimeters (cm).

    Baseline to Week 6

  • Diaphragm Excursion (cm)

    Diaphragm excursion represents the vertical movement of the diaphragm during the respiratory cycle, reflecting diaphragmatic mobility and function. Measurements are obtained using ultrasonography and expressed in centimeters (cm).

    Baseline to Week 6

Secondary Outcomes (3)

  • Forced Vital Capacity (FVC)

    Baseline to Week 6

  • Forced Expiratory Volume in one second (FEV1)

    Baseline to Week 6

  • Peak Expiratory Flow (PEF)

    Baseline to Week 6

Study Arms (1)

Threshold Inspiratory Muscle Training

EXPERIMENTAL
Other: Threshold Inspiratory Muscle TrainingDevice: Philips Respironics Threshold IMT device

Interventions

Threshold inspiratory muscle training performed using a threshold loading device to improve inspiratory muscle strength. Training is conducted once daily, five times per week for 6 weeks, with intensity starting at 30% and progressively increasing up to 50% of maximal inspiratory pressure (MIP) based on patient tolerance.

Also known as: Inspiratory Muscle Training (IMT), Threshold IMT
Threshold Inspiratory Muscle Training

A threshold loading device used to provide inspiratory resistance during inspiratory muscle training

Threshold Inspiratory Muscle Training

Eligibility Criteria

Age40 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with a COPD GOLD stage 2
  • Age 40-59 years
  • Maximal Inspiratory Pressure (MIP) value of less than 70 cmH₂O or below the lower limit of normal for their age and gender
  • Clinically stable for at least 4 weeks prior to the study
  • Ready to participate in research and sign informed consent

You may not qualify if:

  • Patients with contraindications to Inspiratory Muscle Training or spirometry (e.g., recent thoracic or abdominal surgery, pneumothorax, or history of spontaneous pneumothorax).
  • Patients participating in other structured respiratory muscle training or pulmonary rehabilitation programs concurrently that could confound the results
  • Patients undergoing other therapies that may affect diaphragmatic muscle measurement results, such as electrical diaphragmatic stimulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Dian M. Sari, MD., M.Sc., Ph.D

    Faculty of Medicine Universitas Padjadjaran Bandung

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dian M. Sari, MD., M.Sc., Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single-group assignment with pretest-posttest assessment. All participants receive threshold inspiratory muscle training, and outcomes are measured before and after the intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 20, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 23, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share